跳至主要内容
临床试验/NCT02503449
NCT02503449Unknown不适用

Multi-center Clinical Trial of Pulmonary Cryptococcosis in China

Zhixin Liang0 个研究点目标入组 260 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
260
主要终点
differences in clinical manifestations of pulmonary cryptococcosis

研究概览

简要总结

The purpose of the study:1.Improve the understanding of the risk factors of pulmonary cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in different conditions;4.Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.

详细描述

  1. Patients corresponding to inclusion criteria and obtaining informed consent are included in the research in department of respiration ward in cooperative hospitals.
  2. Relevant case report forms are created in this study.
  3. Basic information such as age,weight and height is recorded in selected cases.Clinical manifestations,risk factors,laboratory examination,imaging examination,etiological examination and histopathological examination are also recorded in selected cases by case report forms.In addition,antifungal treatment is recorded including name,dose,time of starting treatment and terminate treatment.Causes of terminate treatment and curative effect evaluation should be analysed.
  4. Statistical analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients possess clinical or imaging manifestations of pulmonary infections,with any of the results(by one of following conditions) by microbiological examination or histopathologic examination
  • Cryptococcal capsular polysaccharide antigen of blood or pleural effusion is positive
  • Cryptococcus(fungus culture) is discovered by lower respiratory tract specimens
  • Cryptococcus(pleural effusions culture) is discovered by pleural effusions collected under sterile condition
  • Cryptococcus(pus culture) is discovered by pus smear out of pulmonary infections in disseminated infection patients
  • Cryptococcus(blood culture) is discovered by microscopy of specimens of blood smear
  • Cryptococcus is discovered by culturing of the pathological tissue specimens in aseptic condition
  • Cryptococcal capsular budding yeast with inflammatory reaction is discovered by histopathological examination,cell pathology examination or microscopic examination in aseptic condition

排除标准

  • Patients suffer from acquired immune deficiency syndrome
  • Patients or their legal guardians request to withdraw the clinical research

结局指标

主要结局

differences in clinical manifestations of pulmonary cryptococcosis

时间窗: 30 days

Methods including laboratory examination(routine blood test),imaging examination(chest CT),scoring system(APACHE II score)

次要结局

  • treatment of pulmonary cryptococcosis(30 days)

研究者

发起方
Zhixin Liang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhixin Liang

Chinese Medical Association of respiratory diseases

Chinese PLA General Hospital

相似试验

Clinical Trial of Pulmonary Cryptococcosis in China | 临床试验